Revolo Biotherapeutics
PrivateLast Round
Series B
Sep 21, 2020
Total Funding Raised
$62.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Revolo Biotherapeutics is a clinical-stage biotechnology company that develops therapies designed to reset the immune system to treat autoimmune and allergic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Revolo Biotherapeutics Comparables
Compare Revolo Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| COUR Pharmaceuticals | 83% | |
| Anokion | 81% | |
| AbolerIS Pharma | 81% |
Revolo Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 21, 2020 | ||||
| VC Round | Jun 30, 2018 | ||||
| Series A | Oct 11, 2017 |
Key People
Founding team and executive leadership
Revolo Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Morningside Ventures | Series B |
| Metellus | Series B, VC Round, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 31% MoM, reaching 3.2K.
- May 17, 2026
Monthly visitors grew 192% MoM, reaching 2.4K.
Revolo Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Revolo Biotherapeutics's valuation, stock price, and market status.
Is Revolo Biotherapeutics a public or private company?
Revolo Biotherapeutics is a private company.
What is the current stock price of Revolo Biotherapeutics?
Revolo Biotherapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Revolo Biotherapeutics worth (valuation)?
Valuation information for Revolo Biotherapeutics is not publicly available.
Can I buy Revolo Biotherapeutics stock?
Revolo Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Revolo Biotherapeutics's last funding round?
Revolo Biotherapeutics's most recent funding round was Series B on September 21, 2020.
Who are the main investors in Revolo Biotherapeutics?
Key investors in Revolo Biotherapeutics include Morningside Ventures, Metellus.
Will Revolo Biotherapeutics IPO soon?
No public IPO plans have been announced for Revolo Biotherapeutics.
How can I track Revolo Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Revolo Biotherapeutics's secondary market activity and sign up for updates.